TABLE OF CONTENTS

Preamble ………………………………………………..	3
1. Introduction ………………………………………	3
1.1 Methodology and Evidence Review	3
1.2 Organization of the Writing Committee ………………………………………..	3
1.3 Document Review and Approval …	4
1.4 Health Policy Objectives ……………..	4
1.5 Top 10 Take-Home Messages ……..	4
2. Permanent Pacemakers ………………………	5
2.1 Introduction ………………………………..	5
2.2 Isolated Sinus Node Dysfunction ..	5
2.3 Isolated Congenital Complete Atrioventricular Block ………………………	6
2.4 Atrioventricular Block: Other Considerations …………………………………..	6
2.5 Postoperative Atrioventricular Block ………………………………………………..	7
2.6 Congenital Heart Disease: Specific Considerations …………………………………..	7
2.7 Post Cardiac Transplantation ………	8
2.8 Neuromuscular Diseases and Other Progressive Cardiac Conduction Diseases ………………………….	8
2.9 Neurocardiogenic Syncope …………..	9
2.10 Cardiac Channelopathies …………..	9
2.11 Inflammation/Infection ………………	10
3. Implantable Cardioverter Defibrillators 10
3.1 Introduction ………………………………..	10
3.2 General Recommendations for Implantable Cardioverter Defibrillator
Therapy …………………………………………….	10
3.3 ICD Indications for Cardiac Channelopathies ………………………………..	11
3.3.1 Long QT Syndrome ……………..	11
3.3.2 Catecholaminergic Polymorphic Ventricular Tachycardia ………………………………….	12
3.3.3 Brugada Syndrome ………………	12
3.4 ICD Indications for Cardiomyopathies ……………………………..	13
3.4.1 Hypertrophic Cardiomyopathy	13
3.4.2 Arrhythmogenic Cardiomyopathies …………………………	13
3.4.3 Nonischemic Dilated Cardiomyopathy …………………………..	14
3.5 ICD Indications for Congenital Heart Disease ……………………………………	14
4. Insertable Cardiac Monitors ………………	15
5. CIED Lead Management …………………..	15
6. CIED Follow-up and Ancillary Testing	16
7. Special Considerations ……………………….	17
7.1 CIEDs and Magnetic Resonance Imaging …………………………………………….	17
7.2 CIEDs and Sports Participation ….	18
7.3 Shared Decision-Making ……………..	18
8. Knowledge Gaps and Future Research	18
References ……………………………………………..	19
Appendix 1 Author Relationships With Industry …………………………………………………	22
Appendix 2 Reviewer Relationships With Industry …………………………………………………	26